about
Actinomyces and related organisms in human infectionsAlistipes onderdonkii sp. nov. and Alistipes shahii sp. nov., of human origin.Diversity of Capnocytophaga species in children and description of Capnocytophaga leadbetteri sp. nov. and Capnocytophaga genospecies AHN8471.Detection of multiple pathogenic species in saliva is associated with periodontal infection in adultsPrevotella micans sp. nov., isolated from the human oral cavity.Comparison between cultured small-intestinal and fecal microbiotas in beagle dogs.Pregnancy-induced gingivitis and OMICS in dentistry: in silico modeling and in vivo prospective validation of estradiol-modulated inflammatory biomarkers.Salivary MMP-8, TIMP-1, and ICTP as markers of advanced periodontitis.Microbiology of aggressive periodontitis.Evaluation of four commercial test systems for identification of actinomyces and some closely related speciesAntimicrobial susceptibilities of Peptostreptococcus anaerobius and the newly described Peptostreptococcus stomatis isolated from various human sources.Population-based study of salivary carriage of periodontal pathogens in adults.Performance of MALDI-TOF MS for identification of oral Prevotella species.Hospitalizations and deaths associated with Clostridium difficile infection, Finland, 1996-2004.A dental look at the autistic patient through orofacial pain.Understanding the roles of gingival beta-defensins.Two Cheers for Crohn's Disease and Periodontitis: Beta-Defensin-2 as an Actionable Target to Intervene on Two Clinically Distinct Diseases.Cyclic Dinucleotides in Oral Bacteria and in Oral Biofilms.Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases.Human neutrophil peptide-1 affects matrix metalloproteinase-2, -8 and -9 secretions of oral squamous cell carcinoma cell lines in vitro.Analyses of Gingival Adhesion Molecules in Periodontitis: Theoretical In Silico, Comparative In Vivo, and Explanatory In Vitro Models.An Appeal to the Global Health Community for a Tripartite Innovation: An "Essential Diagnostics List," "Health in All Policies," and "See-Through 21(st) Century Science and Ethics".MMPREDOX/NO interplay in periodontitis and its inhibition with Satureja hortensis L. essential oil.Bioinformatical and in vitro approaches to essential oil-induced matrix metalloproteinase inhibition.Intracellular replication of fusobacteria requires new actin filament formation of epithelial cells.Dipeptidyl peptidase IV and quorum sensing signaling in biofilm-related virulence of Prevotella aurantiaca.Construction and characterization of a multilayered gingival keratinocyte culture model: the TURK-U model.Salivary Concentrations of Interleukin (IL)-1β, IL-17A, and IL-23 Vary in Relation to Periodontal Status.Associations Between Salivary Bone Metabolism Markers and Periodontal Breakdown.Salivary cytokine levels in early gingival inflammation.A Systems Biology Approach to Reveal Putative Host-Derived Biomarkers of Periodontitis by Network Topology Characterization of MMP-REDOX/NO and Apoptosis Integrated Pathways.Focussed microarray analysis of apoptosis in periodontitis and its potential pharmacological targeting by carvacrol.Effect of estradiol on planktonic growth, coaggregation, and biofilm formation of the Prevotella intermedia group bacteria.Clostridium difficile contamination of public tap water distribution system during a waterborne outbreak in Finland.Editorial: Use of Saliva in Diagnosis of Periodontitis: Cumulative Use of Bacterial and Host-Derived Biomarkers.A novel organotypic dento-epithelial culture model: effect of Fusobacterium nucleatum biofilm on B-defensin-2, -3, and LL-37 expression.Biofilm formation enhances the oxygen tolerance and invasiveness of Fusobacterium nucleatum in an oral mucosa culture model.Salivary interleukin-1beta concentration and the presence of multiple pathogens in periodontitis.Prevalence of periodontal bacteria in saliva of Kuwaiti children at different age groups.Anti-biofilm properties of Satureja hortensis L. essential oil against periodontal pathogens.
P50
Q27028059-9F1C8207-0A3E-4A0D-B27A-D2E2DBDC6A4AQ31053671-249D0A02-BD73-4BCF-AA04-DA2FF2FD9AA6Q31143849-73D40611-E894-4089-A246-E525AB963F0EQ33385606-62EFFCD6-91D7-458A-913F-B6B685736130Q33423730-21F994B4-42F4-4A59-BB7B-E834742CF57AQ33913452-C5215E73-26B7-437C-9BBD-29CDDE2B7ED9Q34113871-C1DAEE78-9705-41F7-9708-15D58AFFF1BFQ34117735-0C4F0639-FCB6-4BD1-B7A5-D6C3638F1F38Q35150042-3DB22159-0928-45D8-B6A9-A0488EE0B494Q35551995-E6AF9E45-675B-494F-BC2B-BADF0DFDA76EQ35840020-7E4CA9CC-1A71-4FDF-896D-08CFA36B8BEDQ35947397-42E75E0B-AA0E-4384-A06E-BF9906E04E24Q36355599-143F20C5-1C50-4AFD-8133-71DC23AE0BD2Q37203760-152212D6-A012-4810-AA79-9A0BDEF5025DQ37828157-78533494-E7DA-41D4-A869-31C94192D5A7Q37990507-2F0B8C0F-657A-435B-ABE9-41A4D463FCDBQ38546650-BCFEC371-E9A4-4457-9E00-782938C0B2A4Q38662284-81FDEADF-9550-4993-80F3-4E6230FBFAB1Q38667969-C0699692-8875-4D01-A737-E0793940337AQ38794633-94124651-81F3-4434-9B32-BF5105401853Q38957391-38EC533F-03BE-4A76-9166-9437CA3A4487Q38986223-468FACB2-C7FD-4575-94F2-733AA2F55CCAQ39168283-DB73882D-C9EE-43A8-B3C4-64122327C4BEQ39351440-356D5EC1-414C-43B8-A53F-C7460098627DQ39897348-3B2F0BA0-5639-41C9-9B7E-F089974AC5A3Q40087727-17B80634-BE2A-4CCA-AF27-FA9A08E928C1Q40502027-DDF29035-91E0-44B8-8234-B891F7937565Q40615383-23407537-F3E5-46B0-B124-B74619BCBD85Q41095061-7FEA925B-E59F-4A2D-A97C-A4C3CD7FA4B8Q41442706-6DD31B2A-151F-4985-8029-BCFCE059083AQ41901635-216867E0-363C-4362-B9EE-A26AE0C3006BQ42223868-8FB022DA-DD58-4817-88CC-120A656A4B2EQ42225735-26B0E9F4-B219-4FEC-AEE7-C1B4632787A1Q42270638-7C688E19-6F1A-462C-9A6C-E7323D79B484Q42344745-5BF12613-482B-4CC8-A535-B923F7786A81Q42490311-2F6E7A83-0DD9-4482-8092-718098B1ACD9Q43115865-12EED22D-ECB9-4B8C-AEC3-E35601D1A5BCQ43267927-5CE507E7-B0C1-4835-80B0-768687201471Q43658159-D8A4965D-E1F7-4A6B-88DB-84DF33924292Q44134626-FA0DEF53-E4E2-496B-BC8B-1E6821DF464C
P50
name
Eija Könönen
@en
type
label
Eija Könönen
@en
prefLabel
Eija Könönen
@en